These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11020119)

  • 21. Treatment of narcolepsy: objective studies on methylphenidate, pemoline, and protriptyline.
    Mitler MM; Shafor R; Hajdukovich R; Timms RM; Browman CP
    Sleep; 1986; 9(1 Pt 2):260-4. PubMed ID: 3704451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep practitioners need to be aware of new changes in the labeling of pemoline (CYLERT).
    Littner M
    Sleep; 1999 Nov; 22(7):833. PubMed ID: 10566901
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2012 Oct; 50(10):9-10. PubMed ID: 23053622
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe hypotension in a patient receiving pemoline during general anesthesia.
    Bohringer CH; Jahr JS; Rowell S; Mayer K
    Anesth Analg; 2000 Nov; 91(5):1131-3. PubMed ID: 11049895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of post-traumatic narcolepsy with methylphenidate: a case report.
    Francisco GE; Ivanhoe CB
    Am J Phys Med Rehabil; 1996; 75(1):63-5. PubMed ID: 8645441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychostimulants and psychiatrists: the Trent Adult Psychiatry Psychostimulant Survey.
    Bramble D
    J Psychopharmacol; 2000 Mar; 14(1):67-9. PubMed ID: 10757256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narcolepsy].
    Shimizu T
    Nihon Rinsho; 1998 Feb; 56(2):376-81. PubMed ID: 9503838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA-approved drugs to treat sleep disorders.
    J Psychosoc Nurs Ment Health Serv; 2011 Oct; 49(10):11-2. PubMed ID: 21985567
    [No Abstract]   [Full Text] [Related]  

  • 29. Methylphenidate and narcolepsy: new indication. When modafinil fails.
    Prescrire Int; 2001 Feb; 10(51):7-9. PubMed ID: 11503860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological management of treatment-induced insomnia in ADHD.
    Kratochvil CJ; Lake M; Pliszka SR; Walkup JT
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):499-501. PubMed ID: 15843773
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemoline (Cylert) for minimal brain dysfunction.
    Med Lett Drugs Ther; 1976 Jan; 18(2):5-6. PubMed ID: 1107790
    [No Abstract]   [Full Text] [Related]  

  • 32. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Stimulant therapy in children].
    Steinhausen HC
    Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534
    [No Abstract]   [Full Text] [Related]  

  • 34. The hyperkinetic child: current status.
    Dubey DR
    Compr Ther; 1982 May; 8(5):58-67. PubMed ID: 7094561
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological treatment of sleep disorders and its relationship with neuroplasticity.
    Abad VC; Guilleminault C
    Curr Top Behav Neurosci; 2015; 25():503-53. PubMed ID: 25585962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Narcolepsy in the custodial setting.
    Wall IF
    J Clin Forensic Med; 2005 Oct; 12(5):274-6. PubMed ID: 16198971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of magnesium pemoline and methylphenidate on memory improvement and mood in normal aging subjects.
    Gilbert JG; Donnelly KJ; Zimmer LE; Kubis JF
    Int J Aging Hum Dev; 1973; 4(1):35-51. PubMed ID: 4591659
    [No Abstract]   [Full Text] [Related]  

  • 38. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amphetamines in the management of children's hyperkinesis.
    Singh V; Ling GM
    Bull Narc; 1979; 31(3-4):87-94. PubMed ID: 44685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.